HDM1002 200 mg

DRUG3 trials

Sponsors

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Conditions

Type 2 Diabetes

Phase 2

To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

CompletedNCT06481085

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Type 2 Diabetes

Start: 2024-06-27End: 2025-06-30Updated: 2025-07-28

Phase 3

A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

RecruitingNCT07082114

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Type 2 Diabetes

Start: 2025-07-14End: 2027-05-17Target: 800Updated: 2025-07-24

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

RecruitingNCT07193459

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Type 2 Diabetes

Start: 2025-08-12End: 2027-02-01Target: 360Updated: 2025-09-25